Cue Biopharma (CUE) EPS (Basic) (2017 - 2026)
Cue Biopharma's (CUE) quarterly EPS (Basic) came in at -$13.81 in Q2 2026, down 15519.97% year-over-year from N/an in Q2 2025, and down 61327.14% quarter-over-quarter from $0.02 in Q4 2025.
Powered by 
Analysis
Cue Biopharma (CUE) EPS (Basic) (2017 - 2026) Analysis & Trends
Cue Biopharma has disclosed EPS (Basic) across 10 years of filings, most recently posting -$13.81 for Q2 2026.
- In Q2 2026, EPS (Basic) fell 15519.97% year-over-year to -$13.81; the TTM figure through Jun 2026 stood at -$15.96 (down 3869.97% YoY), while the FY2025 annual figure was -$0.21, up 61.55% from the prior year.
- EPS (Basic) came in at -$13.81 for Q2 2026 at Cue Biopharma, down from $0.02 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.02 in Q4 2025 to a low of -$13.81 in Q2 2026.
- Average EPS (Basic) over 5 years is -$1.03, with a median of -$0.24 recorded in 2024.
- Year-over-year, EPS (Basic) jumped 113.59% in 2025 and slumped 15519.97% in 2026.
- Over 5 years, EPS (Basic) stood at -$0.4 in 2022, then grew by 29.24% to -$0.28 in 2023, then jumped by 41.29% to -$0.17 in 2024, then jumped by 113.59% to $0.02 in 2025, then slumped by 61327.14% to -$13.81 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$13.81 in Q2 2026, $0.02 in Q4 2025, and -$0.07 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Cue Biopharma | 179.95 Mn | 162.53 Mn | - | -13.81 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.81 |
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | -0.07 |
| Jun 30, 2025 | -0.09 |
| Mar 31, 2025 | -0.16 |
| Dec 31, 2024 | -0.17 |
| Sep 30, 2024 | -0.17 |
| Jun 30, 2024 | -0.20 |
| Mar 31, 2024 | -0.24 |
| Dec 31, 2023 | -0.28 |
| Sep 30, 2023 | -0.23 |
| Jun 30, 2023 | -0.29 |
| Mar 31, 2023 | -0.29 |
| Dec 31, 2022 | -0.40 |
| Sep 30, 2022 | -0.31 |
| Jun 30, 2022 | -0.37 |
| Mar 31, 2022 | -0.44 |
| Dec 31, 2021 | -0.25 |
| Sep 30, 2021 | -0.41 |
| Jun 30, 2021 | -0.33 |